Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease
Barbara Miziak, Barbara Błaszczyk, Stanisław J. Czuczwar
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 458-458
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 690
Aducanumab: evidence from clinical trial data and controversies
Rajesh R. Tampi, Brent P. Forester, Marc Agronin
Drugs in Context (2021) Vol. 10, pp. 1-9
Open Access | Times Cited: 150
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Zdeněk Fišar
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1676-1676
Open Access | Times Cited: 53
The Role of Resveratrol in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review
Daiene Santos Buglio, Ledyane Taynara Marton, Lucas Fornari Laurindo, et al.
Journal of Medicinal Food (2022) Vol. 25, Iss. 8, pp. 797-806
Closed Access | Times Cited: 47
Hot Spots for the Use of Intranasal Insulin: Cerebral Ischemia, Brain Injury, Diabetes Mellitus, Endocrine Disorders and Postoperative Delirium
А. О. Шпаков, И. И. Зорина, К. В. Деркач
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3278-3278
Open Access | Times Cited: 29
Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer’s and Parkinson’s diseases
Elizabeth M. Rhea, Alice Babin, P. C. Thomas, et al.
Tissue Barriers (2023) Vol. 12, Iss. 4
Open Access | Times Cited: 27
Protein aggregation: Consequences, mechanism, characterization and inhibitory strategies
Nabeela Majid, Rizwan Hasan Khan
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 125123-125123
Closed Access | Times Cited: 24
Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
Saghar Rabiei Poor, Miren Ettcheto, Amanda Cano, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 890-890
Open Access | Times Cited: 33
Antidepressants in Alzheimer’s Disease: A Focus on the Role of Mirtazapine
Ana Salomé Correia, Nuno Vale
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 930-930
Open Access | Times Cited: 30
Effectiveness of DBS as a treatment for Alzheimer’s disease: Meta-analysis
Julia Scaramal Mello, Gabriela Ilias Bechara, Paulo Henrique Pires de Aguiar
Deep Brain Stimulation (2025)
Open Access
Therapeutic modulation of mitochondrial dynamics by agmatine in neurodegenerative disorders
Dhanshree Nibrad, Amit Shiwal, Manasi Tadas, et al.
Neuroscience (2025)
Closed Access
The Rhesus Macaque as a Translational Model for Neurodegeneration and Alzheimer’s Disease
Gail A. Stonebarger, Heather A. Bimonte‐Nelson, Henryk F. Urbanski
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 26
Crocin nano-chitosan-coated compound improves anxiety disorders, learning, and spatial memory in Alzheimer's model induced by beta-amyloid in rats.
Gholam Hossein Meftahi, Mohsen Khodadadi, Gila Pirzad Jahromi, et al.
PubMed (2024) Vol. 27, Iss. 7, pp. 879-887
Closed Access | Times Cited: 3
Ginsenoside Rg1, lights up the way for the potential prevention of Alzheimer's disease due to its therapeutic effects on the drug-controllable risk factors of Alzheimer's disease
Jiaojiao Wu, Li Zhang, Dong Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116955-116955
Closed Access | Times Cited: 7
Evaluation of Anticholinesterase Activity of the Fungicides Mefentrifluconazole and Pyraclostrobin
Dora Kolić, Goran Šinko
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6310-6310
Open Access | Times Cited: 2
Medha Plus – A novel polyherbal formulation ameliorates cognitive behaviors and disease pathology in models of Alzheimer’s disease
Ramesh Kumar Paidi, Sukanya Sarkar, Naqiya Ambareen, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113086-113086
Open Access | Times Cited: 12
The Transcranial Light Therapy Improves Synaptic Plasticity in the Alzheimer’s Disease Mouse Model
Débora Buendía, Tatiana Guncay, Macarena Oyanedel, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1272-1272
Open Access | Times Cited: 12
Insulin and α-Tocopherol Enhance the Protective Effect of Each Other on Brain Cortical Neurons under Oxidative Stress Conditions and in Rat Two-Vessel Forebrain Ischemia/Reperfusion Injury
И. О. Захарова, L. V. Bayunova, И. И. Зорина, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11768-11768
Open Access | Times Cited: 15
Ankaflavin and Monascin Prevent Fibrillogenesis of Hen Egg White Lysozyme: Focus on Noncovalent and Covalent Interactions
Jingwen Lü, Changyan Dong, Yi Cheng, et al.
The Journal of Physical Chemistry B (2024)
Closed Access | Times Cited: 1
GJA1/CX43 High Expression Levels in the Cervical Spinal Cord of ALS Patients Correlate to Microglia-Mediated Neuroinflammatory Profile
Nunzio Vicario, Paola Castrogiovanni, Rosa Imbesi, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2246-2246
Open Access | Times Cited: 6
New TLC Method Combined with Densitometry for Determination of Sertraline and Fluoxetine in Pharmaceutical Preparations
Alina Pyka
Processes (2022) Vol. 10, Iss. 10, pp. 2083-2083
Open Access | Times Cited: 3
Diosgenin-rich Yam (rhizome of Dioscorea batatas) extract ameliorates cognitive functions and plasma biomarkers for mild cognitive impairment and mild Alzheimer's disease: a randomized controlled trial
Yuna Inada, Chihiro Tohda, Daiki Sasabayashi, et al.
Phytomedicine Plus (2024) Vol. 4, Iss. 3, pp. 100613-100613
Open Access
Exploring the most promising anti ‐ Depressant drug targeting Microtubule Affinity Receptor Kinase 4 involved in Alzheimer’s Disease through molecular docking and molecular dynamics simulation
S Rehan Ahmad, Md. Zeyaullah, Abdullah M. AlShahrani, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0301179-e0301179
Open Access
Red wine and Resveratrol, their effect on human health
Aikaterini Karampatea, Konstantinidou Parthena
Deleted Journal (2023)
Open Access | Times Cited: 1
Medicinal Perspectives of Retinoids (Review)
L. V. Kovalenko, A. G. Polivanova, Alexey P. Ilyin, et al.
Drug development & registration (2023)
Open Access
Page 1 - Next Page

Scroll to top